"Michelle brings an exceptional combination of scientific acumen, business strategy, and global biotech experience," said Andrew Busey, Form Bio co-founder and outgoing CEO. "She's the right leader at ...

OpenAI’s underwhelming new GPT-5 model suggests progress is slowing – and competition is changing. Everyone is asking: what ...

Rene Veloso, JD, MBA, joins KIFFIK to lead investor relations and secure new funding to fuel clinical operations Rubix Life ...

Silicon Valley investors appear to have little anxiety about slowing progress in AI. Start-up valuations continue to soar, as ...

More and more universities are bringing in corporate-style marketing chiefs. New research shows what they’re gaining – and ...

Jon Walsh, founder, chief scientific officer, Unlearn, explains how AI and digital twins are helping clinical trials become more efficient, patient-centric, and capable of supporting innovative study ...

Revenue-- Revenue net of returns was $86,000, reflecting intentional reductions in ClearUp marketing and unit sales. Operating expenses-- Operating expenses were $2.0 million, up from $1.3 million in ...

MiNK Therapeutics(NASDAQ:INKT) reported its fiscal second quarter ended June 30, 2025, on Aug. 14, 2025, posting a $4.2 million net loss and announcing a $13 million equity raise after quarter-end, ...

Traws Pharma, Inc. ( NASDAQ: TRAW) Q2 2025 Earnings Conference Call August 14, 2025 8:30 AM ET Charles Parker - Interim Chief Financial Officer David Pauza - Corporate Participant Iain D. Dukes - ...

The Glaucoma Research Foundation (GRF) announced it has appointed Cynthia Steel, PhD, MBA, as Chief Scientific Officer (CSO).

Compelling new ARD-201 preclinical data informs optimized Phase 2 clinical development strategy of obesity programs: Phase 2 POWER trial of oral ARD-201 to focus on weight rebound in patients ...